Revised Disclosure under Regulation 30 - Acquisition. Changes in Annexure 1 of the Disclosure filed on 04th August 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemkart India Ltd has filed a revised disclosure regarding its Rs. 1.48 Crore investment in its subsidiary Easy Raw Materials Private Limited through a Rights Issue. The investment involves 14,85,000 equity shares at Rs. 10 each, with the company's shareholding in the subsidiary remaining at 99% both pre and post-allotment. The revised filing updates details under the 'Objects and Effects of Acquisition' section of Annexure 1, clarifying that the investment is part of IPO proceeds utilization towards commissioning the subsidiary's manufacturing unit. The subsidiary, incorporated in 2020, trades in pharma products and nutritional supplements and reported nil turnover, a loss of Rs. 12.68 Lakhs, and negative net worth of Rs. 11.93 Lakhs as of March 31, 2025. The transaction is a cash, arm's-length related party deal with no change in control.
This is a minor capital infusion into an already-controlled subsidiary, so there is no change in ownership or control for Chemkart shareholders. The focus is on deploying IPO proceeds to set up a manufacturing unit, which could support future revenue growth but the subsidiary is currently loss-making with no turnover.